This report studies the global market size of Orally Disintegrating Tablet Excipient in key regions like North America, Europe, China and Japan, focuses on the consumption of Orally Disintegrating Tablet Excipient in these regions.
This research report categorizes the global Orally Disintegrating Tablet Excipient market by top players/brands, region, type and end user. This report also studies the global Orally Disintegrating Tablet Excipient market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
BASF
JRS Pharma
Roquette
ABF Ingredients
DFE Pharma
Evonik
Merck KGaA
Ashland
Meggle Pharma
Shin-Etsu
Fuji Chemical Industries
McePharma (Vivesa holding)
Cargill Incorporated
Daicel Corporation
Anhui Sunhere Pharmaceutical
Orally Disintegrating Tablet Excipient market size by Type
Binders
Glidents
Diluents
Disintegrants
Others
Binders had the biggest market share of 37% in 2018.
Orally Disintegrating Tablet Excipient market size by Applications
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Anti-Epileptics Drug is the greatest segment of Orally Disintegrating Tablet Excipient application, with a share of 37% in 2018.
Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Orally Disintegrating Tablet Excipient market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Orally Disintegrating Tablet Excipient market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Orally Disintegrating Tablet Excipient companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Orally Disintegrating Tablet Excipient submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Orally Disintegrating Tablet Excipient are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Orally Disintegrating Tablet Excipient market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
This research report categorizes the global Orally Disintegrating Tablet Excipient market by top players/brands, region, type and end user. This report also studies the global Orally Disintegrating Tablet Excipient market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
BASF
JRS Pharma
Roquette
ABF Ingredients
DFE Pharma
Evonik
Merck KGaA
Ashland
Meggle Pharma
Shin-Etsu
Fuji Chemical Industries
McePharma (Vivesa holding)
Cargill Incorporated
Daicel Corporation
Anhui Sunhere Pharmaceutical
Orally Disintegrating Tablet Excipient market size by Type
Binders
Glidents
Diluents
Disintegrants
Others
Binders had the biggest market share of 37% in 2018.
Orally Disintegrating Tablet Excipient market size by Applications
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Anti-Epileptics Drug is the greatest segment of Orally Disintegrating Tablet Excipient application, with a share of 37% in 2018.
Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Orally Disintegrating Tablet Excipient market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Orally Disintegrating Tablet Excipient market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Orally Disintegrating Tablet Excipient companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Orally Disintegrating Tablet Excipient submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Orally Disintegrating Tablet Excipient are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Orally Disintegrating Tablet Excipient market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Orally Disintegrating Tablet Excipient Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Type
1.4.2 Binders
1.4.3 Glidents
1.4.4 Diluents
1.4.5 Disintegrants
1.4.6 Others
1.5 Market by Application
1.5.1 Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Application
1.5.2 Anti-Psychotics Drug
1.5.3 Anti-Epileptics Drug
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Orally Disintegrating Tablet Excipient Market Size
2.1.1 Global Orally Disintegrating Tablet Excipient Revenue 2014-2025
2.1.2 Global Orally Disintegrating Tablet Excipient Sales 2014-2025
2.2 Orally Disintegrating Tablet Excipient Growth Rate by Regions
2.2.1 Global Orally Disintegrating Tablet Excipient Sales by Regions
2.2.2 Global Orally Disintegrating Tablet Excipient Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Orally Disintegrating Tablet Excipient Sales by Manufacturers
3.1.1 Orally Disintegrating Tablet Excipient Sales by Manufacturers
3.1.2 Orally Disintegrating Tablet Excipient Sales Market Share by Manufacturers
3.2 Orally Disintegrating Tablet Excipient Revenue by Manufacturers
3.2.1 Orally Disintegrating Tablet Excipient Revenue by Manufacturers (2014-2019)
3.2.2 Orally Disintegrating Tablet Excipient Revenue Share by Manufacturers (2014-2019)
3.3 Orally Disintegrating Tablet Excipient Price by Manufacturers
3.4 Orally Disintegrating Tablet Excipient Manufacturing Base Distribution, Product Types
3.4.1 Orally Disintegrating Tablet Excipient Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Orally Disintegrating Tablet Excipient Product Type
3.4.3 Date of International Manufacturers Enter into Orally Disintegrating Tablet Excipient Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Orally Disintegrating Tablet Excipient Sales by Type
4.2 Global Orally Disintegrating Tablet Excipient Revenue by Type
4.3 Orally Disintegrating Tablet Excipient Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Orally Disintegrating Tablet Excipient Breakdown Data by Application
6 North America
6.1 North America Orally Disintegrating Tablet Excipient by Country
6.1.1 North America Orally Disintegrating Tablet Excipient Sales by Country
6.1.2 North America Orally Disintegrating Tablet Excipient Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Orally Disintegrating Tablet Excipient by Type
6.3 North America Orally Disintegrating Tablet Excipient by Application
7 Europe
7.1 Europe Orally Disintegrating Tablet Excipient by Country
7.1.1 Europe Orally Disintegrating Tablet Excipient Sales by Country
7.1.2 Europe Orally Disintegrating Tablet Excipient Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Orally Disintegrating Tablet Excipient by Type
7.3 Europe Orally Disintegrating Tablet Excipient by Application
8 Asia Pacific
8.1 Asia Pacific Orally Disintegrating Tablet Excipient by Region
8.1.1 Asia Pacific Orally Disintegrating Tablet Excipient Sales by Region
8.1.2 Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Orally Disintegrating Tablet Excipient by Type
8.3 Asia Pacific Orally Disintegrating Tablet Excipient by Application
9 Central & South America
9.1 Central & South America Orally Disintegrating Tablet Excipient by Country
9.1.1 Central & South America Orally Disintegrating Tablet Excipient Sales by Country
9.1.2 Central & South America Orally Disintegrating Tablet Excipient Revenue by Country
9.1.3 Brazil
9.2 Central & South America Orally Disintegrating Tablet Excipient by Type
9.3 Central & South America Orally Disintegrating Tablet Excipient by Application
10 Middle East and Africa
10.1 Middle East and Africa Orally Disintegrating Tablet Excipient by Country
10.1.1 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country
10.1.2 Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Orally Disintegrating Tablet Excipient by Type
10.3 Middle East and Africa Orally Disintegrating Tablet Excipient by Application
11 Company Profiles
11.1 BASF
11.1.1 BASF Company Details
11.1.2 Company Business Overview
11.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.1.4 BASF Orally Disintegrating Tablet Excipient Products Offered
11.1.5 BASF Recent Development
11.2 JRS Pharma
11.2.1 JRS Pharma Company Details
11.2.2 Company Business Overview
11.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Products Offered
11.2.5 JRS Pharma Recent Development
11.3 Roquette
11.3.1 Roquette Company Details
11.3.2 Company Business Overview
11.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Roquette Orally Disintegrating Tablet Excipient Products Offered
11.3.5 Roquette Recent Development
11.4 ABF Ingredients
11.4.1 ABF Ingredients Company Details
11.4.2 Company Business Overview
11.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Products Offered
11.4.5 ABF Ingredients Recent Development
11.5 DFE Pharma
11.5.1 DFE Pharma Company Details
11.5.2 Company Business Overview
11.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Products Offered
11.5.5 DFE Pharma Recent Development
11.6 Evonik
11.6.1 Evonik Company Details
11.6.2 Company Business Overview
11.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Evonik Orally Disintegrating Tablet Excipient Products Offered
11.6.5 Evonik Recent Development
11.7 Merck KGaA
11.7.1 Merck KGaA Company Details
11.7.2 Company Business Overview
11.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Products Offered
11.7.5 Merck KGaA Recent Development
11.8 Ashland
11.8.1 Ashland Company Details
11.8.2 Company Business Overview
11.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Ashland Orally Disintegrating Tablet Excipient Products Offered
11.8.5 Ashland Recent Development
11.9 Meggle Pharma
11.9.1 Meggle Pharma Company Details
11.9.2 Company Business Overview
11.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Products Offered
11.9.5 Meggle Pharma Recent Development
11.10 Shin-Etsu
11.10.1 Shin-Etsu Company Details
11.10.2 Company Business Overview
11.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Products Offered
11.10.5 Shin-Etsu Recent Development
11.11 Fuji Chemical Industries
11.12 McePharma (Vivesa holding)
11.13 Cargill Incorporated
11.14 Daicel Corporation
11.15 Anhui Sunhere Pharmaceutical
12 Future Forecast
12.1 Orally Disintegrating Tablet Excipient Market Forecast by Regions
12.1.1 Global Orally Disintegrating Tablet Excipient Sales Forecast by Regions 2019-2025
12.1.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Regions 2019-2025
12.2 Orally Disintegrating Tablet Excipient Market Forecast by Type
12.2.1 Global Orally Disintegrating Tablet Excipient Sales Forecast by Type 2019-2025
12.2.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Type 2019-2025
12.3 Orally Disintegrating Tablet Excipient Market Forecast by Application
12.4 North America Orally Disintegrating Tablet Excipient Forecast
12.5 Europe Orally Disintegrating Tablet Excipient Forecast
12.6 Asia Pacific Orally Disintegrating Tablet Excipient Forecast
12.7 Central & South America Orally Disintegrating Tablet Excipient Forecast
12.8 Middle East and Africa Orally Disintegrating Tablet Excipient Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Orally Disintegrating Tablet Excipient Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
1 Study Coverage
1.1 Orally Disintegrating Tablet Excipient Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Type
1.4.2 Binders
1.4.3 Glidents
1.4.4 Diluents
1.4.5 Disintegrants
1.4.6 Others
1.5 Market by Application
1.5.1 Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Application
1.5.2 Anti-Psychotics Drug
1.5.3 Anti-Epileptics Drug
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Orally Disintegrating Tablet Excipient Market Size
2.1.1 Global Orally Disintegrating Tablet Excipient Revenue 2014-2025
2.1.2 Global Orally Disintegrating Tablet Excipient Sales 2014-2025
2.2 Orally Disintegrating Tablet Excipient Growth Rate by Regions
2.2.1 Global Orally Disintegrating Tablet Excipient Sales by Regions
2.2.2 Global Orally Disintegrating Tablet Excipient Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Orally Disintegrating Tablet Excipient Sales by Manufacturers
3.1.1 Orally Disintegrating Tablet Excipient Sales by Manufacturers
3.1.2 Orally Disintegrating Tablet Excipient Sales Market Share by Manufacturers
3.2 Orally Disintegrating Tablet Excipient Revenue by Manufacturers
3.2.1 Orally Disintegrating Tablet Excipient Revenue by Manufacturers (2014-2019)
3.2.2 Orally Disintegrating Tablet Excipient Revenue Share by Manufacturers (2014-2019)
3.3 Orally Disintegrating Tablet Excipient Price by Manufacturers
3.4 Orally Disintegrating Tablet Excipient Manufacturing Base Distribution, Product Types
3.4.1 Orally Disintegrating Tablet Excipient Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Orally Disintegrating Tablet Excipient Product Type
3.4.3 Date of International Manufacturers Enter into Orally Disintegrating Tablet Excipient Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Orally Disintegrating Tablet Excipient Sales by Type
4.2 Global Orally Disintegrating Tablet Excipient Revenue by Type
4.3 Orally Disintegrating Tablet Excipient Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Orally Disintegrating Tablet Excipient Breakdown Data by Application
6 North America
6.1 North America Orally Disintegrating Tablet Excipient by Country
6.1.1 North America Orally Disintegrating Tablet Excipient Sales by Country
6.1.2 North America Orally Disintegrating Tablet Excipient Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Orally Disintegrating Tablet Excipient by Type
6.3 North America Orally Disintegrating Tablet Excipient by Application
7 Europe
7.1 Europe Orally Disintegrating Tablet Excipient by Country
7.1.1 Europe Orally Disintegrating Tablet Excipient Sales by Country
7.1.2 Europe Orally Disintegrating Tablet Excipient Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Orally Disintegrating Tablet Excipient by Type
7.3 Europe Orally Disintegrating Tablet Excipient by Application
8 Asia Pacific
8.1 Asia Pacific Orally Disintegrating Tablet Excipient by Region
8.1.1 Asia Pacific Orally Disintegrating Tablet Excipient Sales by Region
8.1.2 Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Orally Disintegrating Tablet Excipient by Type
8.3 Asia Pacific Orally Disintegrating Tablet Excipient by Application
9 Central & South America
9.1 Central & South America Orally Disintegrating Tablet Excipient by Country
9.1.1 Central & South America Orally Disintegrating Tablet Excipient Sales by Country
9.1.2 Central & South America Orally Disintegrating Tablet Excipient Revenue by Country
9.1.3 Brazil
9.2 Central & South America Orally Disintegrating Tablet Excipient by Type
9.3 Central & South America Orally Disintegrating Tablet Excipient by Application
10 Middle East and Africa
10.1 Middle East and Africa Orally Disintegrating Tablet Excipient by Country
10.1.1 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country
10.1.2 Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Orally Disintegrating Tablet Excipient by Type
10.3 Middle East and Africa Orally Disintegrating Tablet Excipient by Application
11 Company Profiles
11.1 BASF
11.1.1 BASF Company Details
11.1.2 Company Business Overview
11.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.1.4 BASF Orally Disintegrating Tablet Excipient Products Offered
11.1.5 BASF Recent Development
11.2 JRS Pharma
11.2.1 JRS Pharma Company Details
11.2.2 Company Business Overview
11.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Products Offered
11.2.5 JRS Pharma Recent Development
11.3 Roquette
11.3.1 Roquette Company Details
11.3.2 Company Business Overview
11.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Roquette Orally Disintegrating Tablet Excipient Products Offered
11.3.5 Roquette Recent Development
11.4 ABF Ingredients
11.4.1 ABF Ingredients Company Details
11.4.2 Company Business Overview
11.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Products Offered
11.4.5 ABF Ingredients Recent Development
11.5 DFE Pharma
11.5.1 DFE Pharma Company Details
11.5.2 Company Business Overview
11.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Products Offered
11.5.5 DFE Pharma Recent Development
11.6 Evonik
11.6.1 Evonik Company Details
11.6.2 Company Business Overview
11.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Evonik Orally Disintegrating Tablet Excipient Products Offered
11.6.5 Evonik Recent Development
11.7 Merck KGaA
11.7.1 Merck KGaA Company Details
11.7.2 Company Business Overview
11.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Products Offered
11.7.5 Merck KGaA Recent Development
11.8 Ashland
11.8.1 Ashland Company Details
11.8.2 Company Business Overview
11.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Ashland Orally Disintegrating Tablet Excipient Products Offered
11.8.5 Ashland Recent Development
11.9 Meggle Pharma
11.9.1 Meggle Pharma Company Details
11.9.2 Company Business Overview
11.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Products Offered
11.9.5 Meggle Pharma Recent Development
11.10 Shin-Etsu
11.10.1 Shin-Etsu Company Details
11.10.2 Company Business Overview
11.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Products Offered
11.10.5 Shin-Etsu Recent Development
11.11 Fuji Chemical Industries
11.12 McePharma (Vivesa holding)
11.13 Cargill Incorporated
11.14 Daicel Corporation
11.15 Anhui Sunhere Pharmaceutical
12 Future Forecast
12.1 Orally Disintegrating Tablet Excipient Market Forecast by Regions
12.1.1 Global Orally Disintegrating Tablet Excipient Sales Forecast by Regions 2019-2025
12.1.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Regions 2019-2025
12.2 Orally Disintegrating Tablet Excipient Market Forecast by Type
12.2.1 Global Orally Disintegrating Tablet Excipient Sales Forecast by Type 2019-2025
12.2.2 Global Orally Disintegrating Tablet Excipient Revenue Forecast by Type 2019-2025
12.3 Orally Disintegrating Tablet Excipient Market Forecast by Application
12.4 North America Orally Disintegrating Tablet Excipient Forecast
12.5 Europe Orally Disintegrating Tablet Excipient Forecast
12.6 Asia Pacific Orally Disintegrating Tablet Excipient Forecast
12.7 Central & South America Orally Disintegrating Tablet Excipient Forecast
12.8 Middle East and Africa Orally Disintegrating Tablet Excipient Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Orally Disintegrating Tablet Excipient Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
